Izotropic Corporation (OTCMKTS:IZOZF – Get Free Report) saw a significant decrease in short interest during the month of October. As of October 30th, there was short interest totaling 9,609 shares, a decrease of 89.6% from the October 15th total of 92,598 shares. Based on an average daily trading volume, of 67,127 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the shares of the stock are short sold.
Izotropic Stock Performance
OTCMKTS IZOZF opened at $0.10 on Wednesday. The business has a 50 day simple moving average of $0.13 and a two-hundred day simple moving average of $0.17. Izotropic has a 1-year low of $0.07 and a 1-year high of $0.29.
Izotropic (OTCMKTS:IZOZF – Get Free Report) last released its quarterly earnings data on Monday, September 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). As a group, equities analysts anticipate that Izotropic will post 0.03 EPS for the current year.
About Izotropic
Izotropic Corporation is a medical technology company focused on developing dedicated breast computed tomography (CT) imaging systems. Its principal product is the IzoView breast CT system, designed to produce three-dimensional images of the breast without the compression typically used in conventional mammography. The company’s technology is intended to support breast-cancer screening and diagnostic imaging by providing detailed volumetric images that may help clinicians evaluate breast tissue and abnormalities.
See Also
- Five stocks we like better than Izotropic
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
Receive News & Ratings for Izotropic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Izotropic and related companies with MarketBeat.com's FREE daily email newsletter.
